Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensity-Modulated Radiotherapy Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

NCT07376603 is registered in ClinicalTrials.gov with Qiaojuan Guo as lead sponsor.

NCT NCT07376603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07376603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensity-Modulated Radiotherapy Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
Lead sponsor
Qiaojuan Guo
Phase
Observational
Overall status
Recruiting
Start date
January 12, 2026
Completion date
December 31, 2030
Enrollment
169 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intensity-modulated radiotherapy, nasopharyngeal cancinoma (npc), stage ib